161 related articles for article (PubMed ID: 34816516)
1. Utility of SOX11 for the diagnosis of solid pseudopapillary neoplasm of the pancreas on cytological preparations.
Dinarvand P; Wang WL; Roy-Chowdhuri S
Cytopathology; 2022 Mar; 33(2):216-221. PubMed ID: 34816516
[TBL] [Abstract][Full Text] [Related]
2. Immunocytochemistry for SOX-11 and TFE3 as diagnostic markers for solid pseudopapillary neoplasms of the pancreas in FNA biopsies.
Foo WC; Harrison G; Zhang X
Cancer Cytopathol; 2017 Nov; 125(11):831-837. PubMed ID: 29045075
[TBL] [Abstract][Full Text] [Related]
3. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (PAX8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and Pancreatic Neuroendocrine Tumors.
Lu H; Allende D; Liu X; Zhang Y
Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
[TBL] [Abstract][Full Text] [Related]
4. [Expression and significance of INSM1 and SOX11 in pancreatic neuroendocrine tumor and solid pseudopapillary neoplasm].
Cao Z; Cen HB; Zhao JH; Mei J; Qin LZ; Liao W; Ao QL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 55(4):575-581. PubMed ID: 37534634
[TBL] [Abstract][Full Text] [Related]
5. Solid-pseudopapillary neoplasm of the pancreas: awareness of unusual clinical presentations and morphology of the clear cell variant can prevent diagnostic errors.
Zhao P; deBrito P; Ozdemirli M; Sidawy MK
Diagn Cytopathol; 2013 Oct; 41(10):889-95. PubMed ID: 23584981
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of pancreatic solid pseudopapillary neoplasms using cell-blocks and immunohistochemical evaluation of endoscopic ultrasound-guided fine needle aspiration biopsy specimens.
Ardengh JC; Lopes CV; Venco FE; Machado MA
Cytopathology; 2021 Jan; 32(1):50-56. PubMed ID: 32816310
[TBL] [Abstract][Full Text] [Related]
7. E-cadherin/beta-catenin and CD10: a limited immunohistochemical panel to distinguish pancreatic endocrine neoplasm from solid pseudopapillary neoplasm of the pancreas on endoscopic ultrasound-guided fine-needle aspirates of the pancreas.
Burford H; Baloch Z; Liu X; Jhala D; Siegal GP; Jhala N
Am J Clin Pathol; 2009 Dec; 132(6):831-9. PubMed ID: 19926573
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic Utility of LEF1 Immunostain in Cytology Specimens of Solid Pseudopapillary Neoplasm of Pancreas].
Farzaneh T; Nowroozizadeh B; Han M; Lee W
Acta Cytol; 2021; 65(3):250-256. PubMed ID: 33887729
[TBL] [Abstract][Full Text] [Related]
9. The usefulness of lymphoid enhancer-binding factor 1 and androgen receptor in diagnosing solid pseudopapillary neoplasm of the pancreas on cytopathology.
McHugh KE; Stelow EB; Harrison GP; Policarpio-Nicolas MLC
Cancer Cytopathol; 2019 Nov; 127(11):700-707. PubMed ID: 31584754
[TBL] [Abstract][Full Text] [Related]
10. Large, clear cytoplasmic vacuolation: an under-recognized cytologic clue to distinguish solid pseudopapillary neoplasms of the pancreas from pancreatic endocrine neoplasms on fine-needle aspiration.
Jhala N; Siegal GP; Jhala D
Cancer; 2008 Aug; 114(4):249-54. PubMed ID: 18484644
[TBL] [Abstract][Full Text] [Related]
11. Utility of cytomorphology in distinguishing solid pseudopapillary neoplasm of pancreas from pancreatic neuroendocrine tumor with emphasis on nuclear folds and nuclear grooves.
Misra S; Saran RK; Srivastava S; Barman S; Dahale A
Diagn Cytopathol; 2019 Jun; 47(6):531-540. PubMed ID: 30677247
[TBL] [Abstract][Full Text] [Related]
12. Fine needle aspiration cytology with the aid of immunocytochemistry on cell-block confirms the diagnosis of solid pseudopapillary neoplasm of the pancreas.
Singh P; Kumar P; Rohilla M; Gupta P; Gupta N; Dey P; Srinivasan R; Rajwanshi A; Nada R
Cytopathology; 2021 Jan; 32(1):57-64. PubMed ID: 32319130
[TBL] [Abstract][Full Text] [Related]
13. TFE3 is a diagnostic marker for solid pseudopapillary neoplasms of the pancreas.
Jiang Y; Xie J; Wang B; Mu Y; Liu P
Hum Pathol; 2018 Nov; 81():166-175. PubMed ID: 30030118
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SOX11 and TFE3 in Solid-Pseudopapillary Neoplasms of the Pancreas.
Harrison G; Hemmerich A; Guy C; Perkinson K; Fleming D; McCall S; Cardona D; Zhang X
Am J Clin Pathol; 2017 Dec; 149(1):67-75. PubMed ID: 29272888
[TBL] [Abstract][Full Text] [Related]
15. Solid-Pseudopapillary neoplasm of the pancreas: A clinicopathological review of 20 cases including rare examples.
Ersen A; Agalar AA; Ozer E; Agalar C; Unek T; Egeli T; Ozbilgin M; Astarcioglu I; Olguner M; Obuz F; Sagol O
Pathol Res Pract; 2016 Nov; 212(11):1052-1058. PubMed ID: 28327291
[TBL] [Abstract][Full Text] [Related]
16. Identification of potential biomarkers to differentially diagnose solid pseudopapillary tumors and pancreatic malignancies via a gene regulatory network.
Li P; Hu Y; Yi J; Li J; Yang J; Wang J
J Transl Med; 2015 Nov; 13():361. PubMed ID: 26578390
[TBL] [Abstract][Full Text] [Related]
17. Synchronous pancreatic solid pseudopapillary neoplasm and intraductal papillary mucinous neoplasm.
Hirabayashi K; Zamboni G; Ito H; Ogawa M; Kawaguchi Y; Yamashita T; Nakagohri T; Nakamura N
World J Gastroenterol; 2013 Jun; 19(21):3358-63. PubMed ID: 23745041
[TBL] [Abstract][Full Text] [Related]
18. Loss of E-cadherin and cytoplasmic-nuclear expression of beta-catenin are the most useful immunoprofiles in the diagnosis of solid-pseudopapillary neoplasm of the pancreas.
Kim MJ; Jang SJ; Yu E
Hum Pathol; 2008 Feb; 39(2):251-8. PubMed ID: 17959228
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of a solid pseudopapillary neoplasm using EUS-FNA.
Fujii M; Saito H; Kato H; Kojima T; Ito M; Ishiyama S; Fujiwara A; Niguma T; Yoshioka M; Shiode J; Mimura T; Yamamoto K
Intern Med; 2013; 52(15):1703-8. PubMed ID: 23903503
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic fine-needle aspiration cytology in patients < 35-years of age: a retrospective review of 174 cases spanning a 17-year period.
Redelman M; Cramer HM; Wu HH
Diagn Cytopathol; 2014 Apr; 42(4):297-301. PubMed ID: 24273058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
